Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.74% | 178.19 | 0.7% | $1350.94m | |
| MRK | Merck & Co., Inc. | 0.21% | 92.61 | 0.7% | $1211.55m | |
| PFE | Pfizer Inc. | -1.20% | 51.68 | 0.9% | $1096.02m | |
| LLY | Eli Lilly & Co. | 0.74% | 327.13 | 1.1% | $1026.00m | |
| BMY | Bristol-Myers Squibb Co. | -1.13% | 75.97 | 1.0% | $991.64m | |
| ABBV | AbbVie, Inc. | 0.03% | 153.85 | 1.9% | $959.73m | |
| AZN | AstraZeneca Plc | -0.67% | 65.51 | 1.0% | $470.96m | |
| SGEN | Seagen Inc. | -1.85% | 176.77 | 5.7% | $326.06m | |
| GSK | GSK Plc | -1.01% | 43.31 | 0.2% | $272.45m | |
| TPTX | Turning Point Therapeutics, Inc. | 0.05% | 75.15 | 0.0% | $199.28m | |
| HZNP | Horizon Therapeutics Plc | 2.38% | 82.76 | 5.4% | $174.09m | |
| NVS | Novartis AG | -0.11% | 84.27 | 0.2% | $172.25m | |
| MRTX | Mirati Therapeutics, Inc. | 1.10% | 71.96 | 1.6% | $150.81m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 1.67% | 150.73 | 8.1% | $150.31m | |
| NVO | Novo Nordisk A/S | -0.40% | 111.19 | 0.1% | $148.30m |
Company Profile
Ocuphire Pharma, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Farmington Hills, MI.